Study Of Some Blood Biomarkers During Bronchial Asthma Flare-ups | ||||
| Benha Medical Journal | ||||
| Article 3, Volume 39, Issue 3, November and December 2022, Page 788-804 PDF (922.78 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/bmfj.2022.135291.1587 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Nouran Ramzy Badr  1; Mohamed Mahmoud Rashad2; Yasser Mahmoud Ismail3; Ahmed Ata Sobeih4
| ||||
| 1Pediatric department, Faculty of medicine, Benha University, Benha, Egypt | ||||
| 2Paediatric Medicine Department, Faculty of Medicine-Benha University | ||||
| 3Clinical pathology department - Faculty of Medicine - Benha Univeristy | ||||
| 4Pediatric , Faculty of medicine , Benha University | ||||
| Abstract | ||||
| Background: Bronchial asthma is one of the most common chronic pediatric diseases. It is a heterogeneous disease with multiple overlapping phenotypes. Biomarkers have been investigated for better phenotype characterization and to identify the response to targeted therapies. Purpose: The study aimed to assess serum periostin level and mean platelet volume in children with asthma flare-ups compared to age and sex-matched healthy controls. Methods: This case-control study included one hundred asthmatic children and fifty healthy children as controls. Both groups were aged 6-12 years. Bronchial asthma was diagnosed according to the Global Initiative for Asthma (1). Blood mean platelet volume and serum periostin levels were assessed for both groups. Results: The mean platelet volume was significantly lower in the patients group (9±1 fL) than in the controls (11±1 fL) (P < 0.001). Serum periostin was significantly higher in the patients group (78.85±26.33 ng/ml) than in the controls (42.72±3.4 ng/ml) (P | ||||
| Keywords | ||||
| Keywords: Asthma; Biomarker; Flare-ups; Periostin | ||||
|
Statistics Article View: 196 PDF Download: 281 |
||||
